Three years after the first FDA approval of CAR-T cell therapy, patients with multiple myeloma are starting to see the therapy emerge in earlier lines.
Hematology Special Issue 2024
CAR-T cell therapy is moving to earlier lines of multiple myeloma treatment.
Advertisement
Advertisement
Trending on CURE
1
Targeted Therapies Are Transforming Lung Cancer Treatment
2
FDA Approves Epkinly Combo in Relapsed/Refractory Follicular Lymphoma
3
Inside the ‘Weird and Wacky’ Frontier of New Targeted Therapy for Lung Cancer
4
Understanding Emerging Cell Therapy in Lung Cancer
5
